Skip to main content
SpringerLink
Log in

Glucocorticoid Treatment in Prenatal and Postnatal Life

  • Chapter
Endocrine Replacement Therapy in Clinical Practice

Part of the book series: Contemporary Endocrinology ((COE))

  • 117 Accesses

Abstract

Untreated, complete glucocorticoid insufficiency leads to circulatory collapse and death. Although uncommon, the possibility of this endocrine emergency engenders vigilance, both for a new diagnosis of adrenal insufficiency as well as for exacerbation of a chronic, known condition. Conversely, overtreatment of adrenal insufficiency with excessive glucocorticoid carries the morbidity associated with iatrogenic Cushing’ s syndrome. Thus, glucocorticoid insufficiency presents two major challenges for clinicians: timely diagnosis and appropriate treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahonen P, Myllarnieini S, Sipila I, et al. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990; 322: 1829–1836.

    Article  PubMed  CAS  Google Scholar 

  2. Betterle C, Volpato M, Greggio AN, et al. Type 2 polyglandular autoimmune disease (Schmidt’s syndrome). J Pediatr Endocrinol Metab 1996; 9: 113–123.

    Article  PubMed  Google Scholar 

  3. Piedrola G, Casado JL, Lopez E, et al. Clinical features of adrenal insufficiency in patients with acquired immunodeficiency syndrome. Clin Endocrinol (Oxf) 1996; 45: 97–101.

    Article  CAS  Google Scholar 

  4. Ihde JK, Turnbull AD, Bajourunas DR. Adrenal insufficiency in the cancer patient: implications for the surgeon. Br J Surg 1990; 77: 1335–1337.

    Article  PubMed  CAS  Google Scholar 

  5. Rao RH, Vagnucci AH, Amico JA. Bilateral massive adrenal hemorrhage: early recognition and treatment. Ann Intern Med 1989; 110: 227–235.

    PubMed  CAS  Google Scholar 

  6. Nieman LK. Cushing’s syndrome treatment. In: C. Wayne Bardin, ed., Current Therapy of Endocrinology and Metabolism. Saunders, Philadephia, 1996, pp. 609–614.

    Google Scholar 

  7. Seminara SB, Achermann JC, Genel M, et al X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females. J Clin Endocrinol Metab 1999; 84: 4501–4509.

    Article  PubMed  CAS  Google Scholar 

  8. Rizzo WB. X-linked adrenoleukodystrophy: a cause of primary adrenal insufficeincy in males. The Endocrinologist. 1992; 2: 177–183.

    Article  Google Scholar 

  9. Ten S, New M, Maclaren N. Clinical review 130: Addison’s disease 2001. J Clin Endocrinol Metab. 2001; 86: 2909–2922.

    Article  PubMed  CAS  Google Scholar 

  10. Merke DP, Camacho CA. Novel basic and clinical aspects of congenital adrenal hyperplasia. Rev Endocr Metab Disord 2001; 2: 289–296.

    Article  PubMed  CAS  Google Scholar 

  11. White PC. Congenital adrenal hyperplasias. Best Pract Res Clin Endocrinol Metab. 2001; 15: 17–41.

    Article  PubMed  CAS  Google Scholar 

  12. Porter FD. RSH/Smith-Lemli-Opitz syndrome: a multiple congenital anomaly/mental retardation syndrome due to an inborn error of cholesterol biosynthesis. Mol Genet Metab 2000; 71: 163–174.

    Article  PubMed  CAS  Google Scholar 

  13. Avgerinos PC, Chrousos GP, Nieman LK, et al. The corticotropin-releasing hormone test in the postoperative evaluation of patients with Cushing’s syndrome. J Clin Endocrinol Metab 1987; 65: 906–913.

    Article  PubMed  CAS  Google Scholar 

  14. Graber AL, Ney RL, Nicholson WE, et al. Natural history of pitutiary-adrenal recovery following long-term suppression with corticosteroid. J Clin Endocrinol Metab 1965; 25: 11–16.

    Article  PubMed  CAS  Google Scholar 

  15. Yamamoto T, Fukuyama J, Haasegawa K, et al. Isolated corticotropin deficiency in adults. Report of 10 cases and reveiw of the literature. Arch Intern Med 1992; 152: 1705–1712.

    Article  PubMed  CAS  Google Scholar 

  16. Oelkers H, Diederich S, Bahr V. Diagnosis and therapy surveillance in Addison’ s disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone. J Clin Endocrinol Metab 1992; 75: 259–264.

    Article  PubMed  CAS  Google Scholar 

  17. Grinspoon SK, Biller BM. Clinical review 62: laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 1994; 79: 923–931.

    Article  PubMed  CAS  Google Scholar 

  18. Dickstein G, Schechner C. Low dose ACTH test - a word of caution to the word of caution: when and how to use it. J Clin Endocrinol Metab 1997; 82: 322.

    Article  PubMed  CAS  Google Scholar 

  19. Borst GC, Michenfelder HI, O’Brian JT. Discordant cortisol responses to exogeneous ACTH and insulin-induced hypoglycemia in patients with pituitary diseases. N Engl J Med 1982; 302: 1462–1464.

    Article  Google Scholar 

  20. Tordjman K, Jaffe A, Trostanetsky Y, et al. Low-dose (1 mcg) adrenocorticotrophin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function: sensitivity, specificity and accuracy in comparison with the high-dose (250 mcg) test. Clin Endocrinol (Oxf) 2000; 52: 633–640.

    Article  CAS  Google Scholar 

  21. Ammari F, Issa BG, Millward E, Scanion MF. A comparison between short ACTH and insulin stress tests for assessing hypothalamo-pituitary-adrenal function. Clin Endocrinol (Oxf) 1996; 44: 473–476.

    Article  CAS  Google Scholar 

  22. Soule SG, Fahie-Wilson M, Tomlinson S. Failure of the short ACTH test to unequivocally diagnose long-standing symptomatic secondary hypoadrenalism. Clin Endocrinol (Oxf) 1996; 44: 137–140.

    Article  CAS  Google Scholar 

  23. Rasmuson S, Olsson T, Hagg E. A low dose ACTH test to assess the function of the hypothalamicpituitary-adrenal axis. Clin Endocrinol (Oxf) 1996; 44: 151–156.

    Article  CAS  Google Scholar 

  24. Cunningham SK, Moore A, McKenna TJ. Normal cortisol response to corticotropin in patients with secondary adrenal failure. Arch Intern Med 1983; 143: 2276–2279.

    Article  PubMed  CAS  Google Scholar 

  25. Clayton RN. Short Synacthen test versus insulin stress test for assessment of the hypothalamo-pituitary-adrenal axis: controversy revisited. Clin Endocrinol (Oxf) 1996; 44: 147–149.

    Article  CAS  Google Scholar 

  26. Schulte HM, Chrousos GP, Avgerinos P, et al. The corticotropin-releasing hormone stimulation test: a possible aid in the evaluation of patients with adrenal insufficiency. J Clin Endocrinol Metab 1984; 58: 1064–1067.

    Article  PubMed  CAS  Google Scholar 

  27. Dluhy RG, Himathongkam T, Greenfield M. Rapid ACTH test with plasma aldosterone levels. Ann Intern Med 1974; 80: 693–696.

    PubMed  CAS  Google Scholar 

  28. New MI. Minireview: 21-hydroxylase deficiency congenital adrenal hyperplasia. J Steroid Biochem Molec Biol 1994; 48: 15–22.

    Article  PubMed  CAS  Google Scholar 

  29. Miller WL. Genetics, diagnosis, and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab 1994; 78: 241–246.

    Article  PubMed  CAS  Google Scholar 

  30. Speiser PW, White PC, Dupont J, et al. Molecular genetic prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency by allele-specific hybridization. Recent Prog Horm Res 1994; 49: 367–371.

    PubMed  CAS  Google Scholar 

  31. Barbat B, Bogyo A, Raux-Dermay MC, et al. Screening of CYP21 gene mutations in 120 French patients affected by steroid 21-hydroxylase deficiency. Hum Mutat 1995; 5: 126–130.

    Article  PubMed  CAS  Google Scholar 

  32. Couillin P, Nicolas H, Boue J, et al. HLA typing of amniotic-fluid cells applied to prenatal diagnosis of congenital adrenal hyperplasia. Lancet 1979; 1: 1076.

    Article  PubMed  CAS  Google Scholar 

  33. Coursin DB, Wood ICE. Corticosteroid supplementation for adrenal insufficiency. JAMA. 2002; 287: 236–240.

    Article  PubMed  CAS  Google Scholar 

  34. Merke DP, Cutler GB. New ideas for medical treatment of congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 2001; 30: 121–135.

    Article  PubMed  CAS  Google Scholar 

  35. David M, Forest MG. Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. J Pediatr 1984; 105: 799–803.

    Article  PubMed  CAS  Google Scholar 

  36. Speiser PW. First trimester prenatal treatment and molecular genetic diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency). J Clin Endocrinol Metab. 1990; 70: 838–848.

    Article  PubMed  CAS  Google Scholar 

  37. Speiser PW, New MI. Prenatal diagnosis and treatment of congenital adrenal hyperplasia. J Ped Endocrinol 1994; 7: 183–191.

    CAS  Google Scholar 

  38. New MI, Carlson A, Obeid J, et al. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab. 2001; 86: 5651–5657

    Article  PubMed  CAS  Google Scholar 

  39. Lajic S, Wedell A, Bui TH, et al. Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1998; 83: 3872–3880.

    Article  PubMed  CAS  Google Scholar 

  40. Mulaikal RM, Migeon CJ, Rock JA. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 1987; 316: 178–188.

    Article  PubMed  CAS  Google Scholar 

  41. Dittmann RW, Kappes ME, Kappes MH. Sexual behavior in adolescent and adult females with congenital adrenal hyperplasia. Psychoneuroendocrinology 1992; 17: 153–170.

    Article  PubMed  CAS  Google Scholar 

  42. Kuhnle U, Bollinger M, Schwarz HP, et al. Partnership and sexuality in adult female patients with congenital adrenal hyperplasia: first results of a cross-sectional qualtiy-of-life evaluation. J Steroid Biochem Mol Biol 1993; 45: 123–126.

    Article  PubMed  CAS  Google Scholar 

  43. Lajic S, Wedell A, Ritzen EM, et al. Scandinavian experience of prenatal treatment of congenital adrenal hyperplasia. Horm Res 1997; 48: 22.

    Article  Google Scholar 

  44. Buescher MA, McClamrock HD, Adashi EY. Cushing’s syndrome in pregnancy. Obstet Gynecol 1992; 79: 130–137.

    PubMed  CAS  Google Scholar 

  45. Forest MG, Betuel H, David M. Prenatal treatment in congenital adrenal hyperplasia due to 21hydroxylase deficiency: update 88 of the French multicentric study. Endocr Res 1989; 15: 277–301.

    Article  PubMed  CAS  Google Scholar 

  46. Don HG, Sippell WG, Willig RP. Praenatale Diagnostik and Therapie des Adrenogenitalen Syndroms (AGS) mit 21-Hydroxylase Defekt. Monatsschr Kinderheilkd 1992; 140: 661–663.

    Google Scholar 

  47. Forest MG, David M, Morel Y. Prenatal diagnosis and treatment of 21-hydroxylase deficiency. J Steroid Biochem Mol Biol 1993; 45: 75–82.

    Article  PubMed  CAS  Google Scholar 

  48. Pang S, Clark AT, Freeman LC, et al. Maternal side-effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia. J Clin Endocrinol Metab 1992; 75: 249–253.

    Article  PubMed  CAS  Google Scholar 

  49. Mercado AB, Wilson RC, Cheng KC, et al. Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. J Clin Endocrinol Metab1995; 80: 2014–2020.

    Google Scholar 

  50. Seckl JR, Miller WL. Commentary: how safe is long-term prenatal glucocorticoid treatment? J Am Med Assoc 1997; 277: 1077–1079.

    Article  CAS  Google Scholar 

  51. Uno H, Lohmiller L, Thieme C, et al. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Brain Res Dev 1990; 53: 157–167.

    CAS  Google Scholar 

  52. Trautman PD, Meyer-Bahlburg HFL, Postelnek J, New MI. Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study. Psychoneuroendocrinology 1995; 20: 439–449.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Lynnette K. Nieman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kristina I. Rother MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Endocrinology, Diabetes and Metabolism, Department of Medicine and Pathology, University of Utah School of Medicine and ARUP Laboratory, Salt Lake City, UT, USA

    A. Wayne Meikle MD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Nieman, L.K., Rother, K.I. (2003). Glucocorticoid Treatment in Prenatal and Postnatal Life. In: Meikle, A.W. (eds) Endocrine Replacement Therapy in Clinical Practice. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-375-0_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-375-0_16

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-416-6

  • Online ISBN: 978-1-59259-375-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation